share_log

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 個醫療保健股在週五的售後市場會議中移動
Benzinga Real-time News ·  2022/12/10 05:36

Gainers

漲幅

  • Regulus Therapeutics (NASDAQ:RGLS) shares moved upwards by 27.1% to $1.75 during Friday's after-market session. The market value of their outstanding shares is at $29.5 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) stock increased by 15.75% to $0.63. At the close, HTG Molecular Diagnostics's trading volume reached 708.4K shares. This is 525.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.9 million.
  • Aclarion (NASDAQ:ACON) shares moved upwards by 9.99% to $0.81. The company's market cap stands at $6.3 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock rose 8.27% to $1.44. The company's market cap stands at $41.2 million.
  • Rubius Therapeutics (NASDAQ:RUBY) shares increased by 8.24% to $0.18. The company's market cap stands at $16.1 million.
  • Anixa Biosciences (NASDAQ:ANIX) stock moved upwards by 6.19% to $4.8. The company's market cap stands at $147.1 million.
  • 常規療法 (納斯達克:RGLS)在周五的售後市場交易時段中,股價向上移動 27.1% 至 1.75 美元。他們的流通股市值為 29.5 百萬美元。
  • HTG 分子診斷 (納斯達克:HTGM) 股票上漲 15.75% 至 0.63 美元。收盤時,HTG 分子診斷的交易量達到 708.4K 股。這是過去 100 天內其平均交易量的 525.5%。其流通股的市值為 690 萬美元。
  • (納斯達克:AON) 股份向上移動 9.99%,至 0.81 美元。該公司的市值為 630 萬美元。
  • 分子胞生物技術 納斯達克:中外交易所股票上漲 8.27%,至 1.44 美元。該公司的市值為 41.2 億美元。
  • 魔法治療 (納斯達克:紅寶石)股份增加了 8.24%,至 0.18 美元。該公司的市值為 1610 萬美元。
  • 阿尼克薩生物科學 (納斯達克:阿尼克斯)股票向上移動 6.19%,至 4.8 美元。該公司的市值為 147.1 億美元。

Losers

失敗者

  • Biolase (NASDAQ:BIOL) shares decreased by 9.3% to $0.65 during Friday's after-market session. The market value of their outstanding shares is at $4.6 million.
  • Ambrx Biopharma (NYSE:AMAM) stock declined by 8.82% to $4.14. Ambrx Biopharma's trading volume hit 22.6 million shares by close, accounting for 23428.7% of its average volume over the last 100 days. The company's market cap stands at $159.8 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares decreased by 6.06% to $0.15. The company's market cap stands at $6.3 million.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) shares fell 5.8% to $0.17. The company's market cap stands at $26.0 million.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares fell 5.09% to $1.68. Trading volume for this security closed at 4.1 million, accounting for 136.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.9 million.
  • Scopus BioPharma (NASDAQ:SCPS) stock decreased by 5.01% to $0.21. The market value of their outstanding shares is at $4.4 million. See Also:
  • 生物酶 (納斯達克:BIOL)股票在周五的售後市場交易時段下跌 9.3%,至 0.65 美元。其流通股的市值為 460 萬美元。
  • 安布爾克斯生物製藥 紐約證券交易所代號:亞馬) 股票下跌 8.82%,至 4.14 美元。安布爾生物製藥的交易量收盤達 2260 萬股,佔過去 100 天內平均交易量的 23428.7%。該公司的市值為 1.58 億美元。
  • 保健三角形 (納斯達克:海港交易所)股份下跌 6.06% 至 0.15 美元。該公司的市值為 630 萬美元。
  • 亚当斯制药公司 納斯達克:ADMP) 股價下跌 5.8%,至 0.17 美元。該公司的市值為 26.0 萬美元。
  • 神經博藥品 納斯達克股票代碼:北歐債券交易所)股價下跌 5.09%,至 1.68 美元。該證券的交易量收於 410 萬,佔過去 100 天內平均全日交易量的 136.0%。他們的流通股市值為一百九十萬美元。
  • 科普斯生物製藥 (納斯達克:SCP) 股票下跌 5.01% 至 0.21 美元。其流通股的市值為 440 萬美元。 另請參閱:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由 Beninga 的自動化內容引擎生成,並由編輯審查。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論